FDA MedWatch Alert Update: Recall - Cleviprex (clevidipine butyrate)
FDA MedWatch Alert Update: Recall - Cleviprex (clevidipine butyrate)
March 17, 2010
Audience: Pharmacists, risk managers.
March 17, 2010
Audience: Pharmacists, risk managers.
The recall has been expanded to include four additional lots with the
lot numbers and expiration dates noted in the firm press release of
March 17, 2010. [Posted 12/17/2009] The Medicines Company and FDA
notified healthcare professionals of a nationwide recall of eleven
lots of Cleviprex (clevidipine butyrate) injectable emulsion,
indicated for treatment of hypertension, due to the potential presence
of particulate matter found to be inert stainless steel...
--
Meds, Material & Equipo Médico, 24 hrs.
esgdivisionmedica.4t.com
If you're having difficulties with your heart your physician may perform an electrocardiograph. These tests are performed on devices known as EKG machines. The test is a painless procedure. No electrical current is introduced into the patient's body during the test. A long-term heart machine is often used on patients during a hospital stay.
ResponderEliminarnitrile exam gloves